Omnicell Corp (OMCL): Price-to-Revenue Ratio

Symbol and logo of brand Omnicell Corp (OMCL)

Top management updates and the adaptation of the governance structure are currently driving the price action. The P/S trajectory clearly demonstrates these changes, where the value of 1.30 characterizes this valuation level. Growth is supported by SaaS solutions and warehouse robotics amid healthcare staffing shortages. The Omnicell, Inc. (OMCL) strategy is based on minimizing medical errors through the global implementation of cloud-based medication management systems.

omnicell.com - OMCL Market Cap to Revenue (period 07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for Omnicell Corp (OMCL)

- current quotes and average value forecast:
- stock exchange capitalization data:
General company analysis:OMCL (omnicell.com)
Core merchandise of omnicell.com

Steady growth in the subscription IT segment of Omnicell, Inc. (OMCL) reduces reliance on cyclical hardware sales, making the company's revenue more predictable. This price-to-sales valuation compares market capitalization with annual turnover, allowing investors to identify if the asset is overbought by analyzing the deviation of the current multiple from historical averages to avoid entering a position at a local price peak.

Who Omnicell, Inc. competes with

VEEV - Price to Sales|Price-to-Revenue Ratio Doximity DOCS|HealthEquity Inc - Price-to-Revenue Ratio|WAY - Price-to-Revenue Ratio|CRVL: Price-to-Revenue Ratio|PRVA (Privia Health Group) - Market Cap to Revenue|huronconsultinggroup.com - Market Capitalization-to-Revenue Ratio|CERT (Certara) - P/S Multiple|GoodRx Inc (GDRX) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Schrödinger Inc. (SDGR)|Phreesia Health - Market Cap to Revenue Ratio|P/S Multiple OMDA (Omada Health Inc)|EVH - Market Cap to Revenue|HSTM: Market Cap to Revenue|Price-to-Revenue Coefficient Definitive Healthcare Corp DH|Consensus (CCSI) - Price-to-Revenue Ratio|Price to Sales Agilon Health Corp (AGL)|Price-to-Revenue Ratio Absci|Market Cap to Revenue soyoung.com (SY)|P/S Multiple NRC|Market Cap to Revenue Spok Holdings Inc SPOK|Price-to-Revenue Ratio OptimizeRx Corp. OPRX|TruBridge Corp - Price-to-Revenue Ratio|Simulations Plus, Inc. - P/S Multiple|Price-to-Revenue Coefficient SOPHiA GENETICS SA SOPH|HCAT (Health Catalyst) - Market Cap to Revenue|CCLD: Market Cap to Sales Volume|Market Cap to Revenue RSSS|DLHC: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio OneMedNet Corporation (ONMD)|Market Cap to Revenue scienture.com SCNX|P/S Multiple HCTI (Healthcare Triangle, Inc.)|iSpecimen Inc (ISPC) - Price to Sales|Bullfrog AI Holdings Inc - P/S Multiple|WORX (SCWorx Inc) - Market Cap to Revenue Ratio|MSP Recovery Inc (MSPR) - Price-to-Revenue Ratio|Price to Sales iCoreConnect (ICCT)|Price-to-Revenue Ratio TRxADE HEALTH|Market Cap to Revenue Orgenesis Inc (ORGS)|Price-to-Revenue Ratio R1 RCM Inc. (RCM)|Sharecare Inc - Market Cap to Revenue Ratio|P/S Multiple STRM (Streamline Health Solutions)|Price-to-Revenue Coefficient syrahealth.com (SYRA)|ApolloMed - P/S Multiple|Model N Inc (MODN) - Market Cap to Revenue|NXGN: P/S Multiple